Liu et al. demonstrated that higher expression of CDK5 was correlated with low/undifferentiated, high pathological stage, lymph node metastasis, shorter median survival, and lower 5-year overall survival in the patients with NSCLC [23]. This evidence concerns the gene CDK5 and metastatic malignant neoplasm in the lymph nodes.